FP201INTERIM RESULTS FROM AN ONGOING PHASE 2 STUDY EVALUATING THE USE OF A MASP-2 INHIBITOR FOR THE TREATMENT OF IGA NEPHROPATHY (IGAN). (13th June 2019) - Barratt, Jonathan; Leifke, Eckhard; Whitaker, Steve; DeTulleo, Louis; Lafayette, Richard